Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. The firm decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
The current price of EVAX is $4.6, it has increased 3.37% in the last trading day.
What are the primary business themes or industries for Evaxion A/S?
Evaxion A/S belongs to Biotechnology industry and the sector is Health Care
What is Evaxion A/S market cap?
Evaxion A/S's current market cap is $38.3M
Is Evaxion A/S a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for Evaxion A/S, including 2 strong buy, 5 buy, 1 hold, 0 sell, and 2 strong sell